Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
BABY > SEC Filings for BABY > Form 8-K on 28-Mar-2014All Recent SEC Filings

Show all filings for NATUS MEDICAL INC

Form 8-K for NATUS MEDICAL INC


28-Mar-2014

Changes in Registrant's Certifying Accountant, Financial Statements and Exhibit


Item 4.01. Changes in Registrant's Certifying Accountant

The Audit Committee ("the Audit Committee") of the Board of Directors of Natus Medical Incorporated (the "Company") conducted a comprehensive and competitive process to determine the Company's independent registered public accounting firm for the Company's 2014 fiscal year. As a result of this process, effective March 24, 2014, the Audit Committee approved the appointment of KPMG LLP as the Company's independent registered public accounting firm for the 2014 fiscal year.

(a) Dismissal of Independent Registered Public Accounting Firm

On March 24, 2014, the Audit Committee approved the dismissal of Deloitte & Touche LLP ("Deloitte") as the Company's independent registered public accounting firm.

Deloitte's reports on the Company's consolidated financial statements as of and for the fiscal years ended December 31, 2013 and 2012 did not contain any adverse opinion or disclaimer of opinion, and were not qualified or modified as to uncertainty, audit scope or accounting principles. Deloitte's report on the audit of the Company's internal control over financial reporting as of December 31, 2013 did not contain an adverse opinion while its report on the audit of the Company's internal control over financial reporting as of December 31, 2012 expressed an adverse opinion on the Company's internal control over financial reporting due to a material weakness, as further described below.

During the two fiscal years ended December 31, 2013 and the subsequent interim period through March 24, 2014, there were no (1) disagreements between the Company and Deloitte on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedures, which disagreements if not resolved to their satisfaction would have caused them to make reference in connection with their opinion to the subject matter of the disagreement, or (2) reportable events as set forth in Item 304(a)(1)(v) of Regulation S-K, except that in its report on the audit of the Company's internal control over financial reporting as of December 31, 2012, Deloitte expressed an adverse opinion on the Company's internal control over financial reporting due to a material weakness. The Company has provided Deloitte with a copy this Form 8-K and requested that Deloitte provide the Company with a letter addressed to the Securities and Exchange Commission stating whether or not Deloitte agrees with the statements related to them made by the Company in this report. A letter from Deloitte & Touche LLP is attached as Exhibit 16.1 of this Form 8-K.

As previously reported in its 2012 Annual Report on Form 10-K filed on April 10, 2013, the Company identified a material weakness related to the Company's controls over the implementation of a single-platform enterprise resource planning application for its operations in North America exclusive of Nicolet.

As reported in its Annual Report on Form 10-K filed on March 17, 2014, during the fiscal year ended December 31, 2013, the Company implemented internal control procedures to address this material weakness and has concluded that it has remediated this material weakness as of December 31, 2013.

(b) Newly Appointed Independent Registered Public Accounting Firm

On March 24, 2014, the Audit Committee approved the appointment of KPMG LLP as the Company's new independent registered public accounting firm, effective immediately, for the fiscal year ending December 31, 2014.




Item 9.01. Financial Statements and Exhibits
(d) Exhibits.

Exhibit  Description
16.1     Letter from Deloitte & Touche LLP addressed to the Securities and
         Exchange Commission, dated as of March 28, 2014


  Add BABY to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for BABY - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.